Literature summary extracted from
Im, H.; Sharpe, M.L.; Strych, U.; Davlieva, M.; Krause, K.L.
The crystal structure of alanine racemase from Streptococcus pneumoniae, a target for structure-based drug design (2011), BMC Microbiol., 11, 116.
Application
EC Number |
Application |
Comment |
Organism |
---|
5.1.1.1 |
medicine |
since it is absent in humans, this enzyme is an attractive target for the development of drugs against Streptococcus pneumoniae and other bacterial pathogens |
Streptococcus pneumoniae |
Cloned(Commentary)
EC Number |
Cloned (Comment) |
Organism |
---|
5.1.1.1 |
expressed in Escherichia coli BL21(DE3) pLysS cells |
Streptococcus pneumoniae |
Crystallization (Commentary)
EC Number |
Crystallization (Comment) |
Organism |
---|
5.1.1.1 |
sitting drop vapor diffusion method, at 4°C in 1.2 M sodium citrate, 0.1 M MES, pH 7.2, and 10% (v/v) glycerol |
Streptococcus pneumoniae |
Organism
EC Number |
Organism |
UniProt |
Comment |
Textmining |
---|
5.1.1.1 |
Streptococcus pneumoniae |
P0A2W8 |
- |
- |
Purification (Commentary)
EC Number |
Purification (Comment) |
Organism |
---|
5.1.1.1 |
ammonium sulfate precipitation, anion-exchange chromatography, hydrophobic interaction chromatography, and gel filtration |
Streptococcus pneumoniae |
Substrates and Products (Substrate)
EC Number |
Substrates |
Comment Substrates |
Organism |
Products |
Comment (Products) |
Rev. |
Reac. |
---|
5.1.1.1 |
L-alanine |
- |
Streptococcus pneumoniae |
D-alanine |
- |
? |
|
Subunits
EC Number |
Subunits |
Comment |
Organism |
---|
5.1.1.1 |
homodimer |
x-ray crystallography |
Streptococcus pneumoniae |
Synonyms
EC Number |
Synonyms |
Comment |
Organism |
---|
5.1.1.1 |
ALR |
- |
Streptococcus pneumoniae |
Cofactor
EC Number |
Cofactor |
Comment |
Organism |
Structure |
---|
5.1.1.1 |
pyridoxal 5'-phosphate |
- |
Streptococcus pneumoniae |
|